Which are the causes of Rosai-Dorfman disease?

The exact cause of Rosai-Dorfman disease remains unknown, though current research suggests it is a non-neoplastic disorder characterized by an abnormal accumulation of histiocytes (a type of white blood cell). While most cases are considered sporadic, recent clinical studies have identified recurring genetic mutations in the MAPK pathway, such as KRAS, MAP2K1, and NRAS, which appear to play a significant role in the development of the condition.

What triggers the development of Rosai-Dorfman disease?

In Rosai-Dorfman disease, the immune system produces an overabundance of histiocytes that gather in the lymph nodes—typically causing them to swell—and occasionally in other tissues like the skin or bone. Researchers are still investigating whether this is triggered by an underlying inflammatory response or a subtle genetic predisposition. Unlike many other conditions, Rosai-Dorfman disease is not considered a cancer, though it involves the uncontrolled growth of these specific cells. It is helpful to think of the condition as an "immune system traffic jam," where cells meant to protect the body instead cluster together in a way that disrupts normal tissue function.

Are there specific genetic factors involved in Rosai-Dorfman disease?

While Rosai-Dorfman disease is rarely inherited, recent advancements in genomic sequencing have revealed somatic mutations in the MAPK/ERK signaling pathway. These mutations occur in the affected cells themselves rather than being passed down from parents. Current scientific understanding includes the following observations regarding the etiology of the condition:

• MAPK pathway mutations: Up to 50% of tested cases have shown mutations in genes such as MAP2K1, KRAS, or NRAS.


• Sporadic nature: The vast majority of cases occur in individuals with no family history of the disorder.


• Somatic vs. Germline: Because these mutations are somatic, they are acquired during the patient's lifetime and are not present in the DNA of every cell in the body.

What is the difference between a cause and a risk factor for this condition?

In medical research, a "cause" is a direct factor that initiates the disease, while a "risk factor" increases the likelihood of a person developing it. For Rosai-Dorfman disease, we have identified clear biological markers (like the mutations mentioned above) that act as drivers of the disease process. However, we have not yet identified external risk factors, such as environmental exposures, diet, or lifestyle choices, that definitively lead to the onset of Rosai-Dorfman disease. Research is ongoing to determine if there is a "second hit" or environmental trigger that activates these dormant genetic mutations in susceptible individuals.

How is current research improving our understanding?

The global medical community is actively working to bridge the gap between identifying these genetic mutations and developing targeted therapies. Because Rosai-Dorfman disease is rare, data sharing is critical. At DiseaseMaps.org, our community of 16 members helps provide a collective history that assists researchers in identifying common patterns. Current clinical trials are shifting toward testing "precision medicine" approaches—using drugs that inhibit the specific MAPK pathway proteins to stop the abnormal histiocyte growth, offering a more tailored alternative to traditional chemotherapy or steroids.

Next steps

• Consult a hematologist or an oncologist who specializes in histiocytic disorders to discuss your specific diagnostic markers.


• Request genetic testing to see if your case involves specific pathway mutations, which may influence treatment options.


• Connect with the 16 members of the DiseaseMaps.org community to share experiences and learn about regional specialists.


• Keep a detailed log of your symptoms and lymph node activity to share with your clinical team during follow-up visits.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• Orphanet: Rosai-Dorfman disease (ORPHA:791)


• NIH Genetic and Rare Diseases (GARD) Information Center: Rosai-Dorfman disease


• OMIM (Online Mendelian Inheritance in Man): Rosai-Dorfman disease entry #155600


• Histiocytosis Association: Patient information and research updates on non-Langerhans cell histiocytosis